. Author manuscript; available in PMC: 2018 Apr 1.

Published in final edited form as: Am J Ophthalmol. 2017 Jan 17;176:102–107. doi: 10.1016/j.ajo.2017.01.004

Table 4.

Quality of life measures showing Short Form-36 Mental Component scores by group at six and 12 months.

Group	2SF-36 score	St Dev	SF improvement	P value
ACZ to open-label ACZ	50.82	6.71
	50.92	8.04	0.1	0.95
PLB to open-label ACZ	45.04	11.97
	49.42	10.08	4.38	0.03
ACZ tapered off ACZ	51.16	5.83
	51.21	8.27	0.06	0.98
PLB to no ACZ	53.48	5.70
	50.13	12.67	−3.35	0.33

ACZ = acetazolamide, PLB = placebo, SF = short form